Denosumab: A novel antiresorptive drug for osteoporosis

Ernest Suresh*, Bo Abrahamsen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstrakt

Denosumab is a novel antiresorptive drug that has been approved for use as a first-line drug for primary and secondary prevention of osteoporotic fractures. The authors discuss the mechanism of action of denosumab, review the evidence for its efficacy and safety in patients with osteoporosis, and offer recommendations for its use in clinical practice.

OriginalsprogEngelsk
Sider (fra-til)105-114
Antal sider10
TidsskriftCleveland Clinic Journal of Medicine
Vol/bind82
Udgave nummer2
DOI
StatusUdgivet - 1 jan. 2015
Udgivet eksterntJa

Fingeraftryk

Udforsk hvilke forskningsemner 'Denosumab: A novel antiresorptive drug for osteoporosis' indeholder.

Citationsformater